Glutamate, a Window on Liver Intermediary Metabolism
Authors:
Open Access
- 1 April 2000
- journal article
- review article
- Published by Elsevier in The Journal of Nutrition
- Vol. 130 (4) , 991S-994S
Abstract
In isotopic experiments, the labeling pattern of glutamate opens a window on hepatic metabolism, particularly the citric acid cycle, gluconeogenesis and fatty acid oxidation. This is because glutamate is in isotopic equilibrium with α-ketoglutarate, whose labeling pattern is influenced by the following: 1) the contributions of glucose and fatty acids to acetyl-CoA, 2) the relative contributions of pyruvate carboxylase and pyruvate dehydrogenase to the entry of pyruvate carbon into the citric acid cycle, and 3) the rate of gluconeogenesis in relation to citric acid cycle activity. In humans and primates, hepatic glutamate can be sampled noninvasively via urinary phenylacetylglutamine, which is formed in liver from phenylacetate (a side product of phenylalanine catabolism) and glutamine (which equilibrates with liver glutamate and α-ketoglutarate). The 14C- or 13C-labeling pattern of the glutamate moiety of phenylacetylglutamine can be measured by sequential degradations to 14CO2, gas chromatography-mass spectrometry or nuclear magnetic resonance (NMR). When phenylacetylglutamine is labeled from singly labeled [14C]- or [13C]substrates, relative metabolic rates can be computed from the labeling pattern using Landau's model. In diabetic patients infused with [3-13C]pyruvate, the noninvasive sampling of hepatic glutamate via phenylacetylglutamine allows one to test the degree of liver insulinization via the (pyruvate carboxylase)/(pyruvate dehydrogenase) activity ratio. This ratio regulates gluconeogenesis in part. Its measurement may allow the identification of patients who might benefit from the intraperitoneal administration of insulin, or from recently developed antidiabetic drugs.Keywords
This publication has 20 references indexed in Scilit:
- Non-invasive tracing of liver intermediary metabolism in normal subjects and in moderately hyperglycaemic NIDDM subjects. Evidence against increased gluconeogenesis and hepatic fatty acid oxidation in NIDDMDiabetologia, 1998
- APPLICATIONS OF MASS ISOTOPOMER ANALYSISTO NUTRITION RESEARCHAnnual Review of Nutrition, 1997
- Estimates of Krebs cycle activity and contributions of gluconeogenesis to hepatic glucose production in fasting healthy subjects and IDDM patientsDiabetologia, 1995
- Disposition of Phenylbutyrate and its Metabolites, Phenylacetate and PhenylacetylglutamineThe Journal of Clinical Pharmacology, 1995
- Tracing Hepatic Gluconeogenesis Relative to Citric Acid Cycle Activity in Vitro and in VivoJournal of Biological Chemistry, 1995
- 13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1994
- Determination of the 13C-Labeling Pattern of Glutamate by Gas Chromatography-Mass SpectrometryAnalytical Biochemistry, 1993
- Estimating Gluconeogenic Rates in NIDDM1993
- Phenylacetylglutamine May Replace Urea as a Vehicle for Waste Nitrogen ExcretionPediatric Research, 1991
- The conjugation of phenylacetic acid in man, sub-human primates and some non-primate speciesProceedings of the Royal Society of London. B. Biological Sciences, 1972